The firm's listing covers sectors AI and Healthcare, and focus areas Antibody Discovery, Biotech, Drug Discovery and Machine Learning; listed stages are Growth and Series A.

Phil Ferneau (Investor) is listed as the contact to pitch at Adimab.

Across the known portfolio, 2 co-investors appear alongside Adimab, including Federated Hermes and Population Health Partners.

Frequently asked questions

What is Adimab?

Adimab is a corporate venture arm based in Lebanon, Ohio, United States, with a known portfolio of one company. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Adimab invest in?

Listed sectors include AI and Healthcare; listed focus areas include Antibody Discovery, Biotech, Drug Discovery and Machine Learning. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Adimab invest at?

Adimab is listed for Growth and Series A rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Adimab?

One person at Adimab is on file, listed as a contact for the firm, with their own profile page.

How do I contact Adimab?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal